Clear Harbor Asset Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,400
| Closed | -$443K | – | 401 |
|
|
2023
Q1 | $443K | Hold |
18,400
| – | – | 0.05% | 248 |
|
|
2022
Q4 | $194K | Buy |
18,400
+900
| +5% | +$9.51K | 0.02% | 314 |
|
|
2022
Q3 | $79K | Buy |
17,500
+800
| +5% | +$3.61K | 0.01% | 339 |
|
|
2022
Q2 | $67K | Hold |
16,700
| – | – | 0.01% | 368 |
|
|
2022
Q1 | $122K | Hold |
16,700
| – | – | 0.01% | 363 |
|
|
2021
Q4 | $94K | Sell |
16,700
-1,100
| -6% | -$6.19K | 0.01% | 374 |
|
|
2021
Q3 | $114K | Hold |
17,800
| – | – | ﹤0.01% | 348 |
|
|
2021
Q2 | $150K | Buy |
17,800
+900
| +5% | +$7.58K | 0.02% | 329 |
|
|
2021
Q1 | $177K | Buy |
16,900
+600
| +4% | +$6.28K | 0.02% | 307 |
|
|
2020
Q4 | $276K | Buy |
16,300
+300
| +2% | +$5.08K | 0.04% | 234 |
|
|
2020
Q3 | $205K | Hold |
16,000
| – | – | 0.04% | 244 |
|
|
2020
Q2 | $226K | Buy |
16,000
+500
| +3% | +$7.06K | 0.04% | 226 |
|
|
2020
Q1 | $143K | Hold |
15,500
| – | – | 0.03% | 235 |
|
|
2019
Q4 | $231K | Hold |
15,500
| – | – | 0.04% | 245 |
|
|
2019
Q3 | $106K | Buy |
+15,500
| New | +$106K | 0.02% | 243 |
|